Mack Mabry
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Oncology top 5%
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
Papers in
-
- Cancer therapeutics and mechanisms 5
- Protein Degradation and Inhibitors 4
- Retinoids in leukemia and cellular processes 4
- Oncology 15
- Lung Cancer Research Studies 5
- Cancer-related Molecular Pathways 5
- Cancer Treatment and Pharmacology 3
- Co-authors
- Barry D. Nelkin (8 shared papers)Stephen B. Baylin (3 shared papers)Michael Borges (3 shared papers)Douglas W. Ball (2 shared papers)R. Ilona Linnoila (1 shared paper)Helgi J. K. van de Velde (1 shared paper)Herbert Chen (1 shared paper)Martin Dunbar (5 shared papers)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (3 papers)Investigational New Drugs (2 papers)Lung Cancer (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Mack Mabry
30 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Hematology 611
- Oncology 534
- Genetics 205
- Molecular Biology 1.2k
- Cancer Research 139
Countries citing papers authored by Mack Mabry
This map shows the geographic impact of Mack Mabry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mack Mabry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mack Mabry more than expected).
Fields of papers citing papers by Mack Mabry
This network shows the impact of papers produced by Mack Mabry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mack Mabry. The network helps show where Mack Mabry may publish in the future.
Co-authors
The 25 scholars most cited alongside Mack Mabry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study Hit paper breakdown → | 2018 | 498 |
| 2 | 1997 | 339 | |
| 3 | 1996 | 139 | |
| 4 | 1996 | 123 | |
| 5 | 1999 | 64 | |
| 6 | 1991 | 60 | |
| 7 | 2014 | 59 | |
| 8 | 2015 | 53 | |
| 9 | 2014 | 50 | |
| 10 | 2017 | 49 | |
| 11 | 1995 | 48 | |
| 12 | 2014 | 46 | |
| 13 | 1999 | 42 | |
| 14 | 2016 | 38 | |
| 15 | 2016 | 36 | |
| 16 | 1999 | 34 | |
| 17 | 1998 | 27 | |
| 18 | Expression of prokaryotic HhaI DNA methyltransferase is transforming and lethal to NIH 3T3 cells. | 1996 | 24 |
| 19 | Induction of markers of normal differentiation in human colon carcinoma cells by the v-rasH oncogene. | 1993 | 24 |
| 20 | 1985 | 16 |
About Mack Mabry
Mack Mabry is a scholar working on Molecular Biology, Oncology, Hematology, Genetics and Pathology and Forensic Medicine, having authored 31 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Cancer therapeutics and mechanisms (5 papers), Lung Cancer Research Studies (5 papers), Cancer-related Molecular Pathways (5 papers), Protein Degradation and Inhibitors (4 papers), Retinoids in leukemia and cellular processes (4 papers), Cancer Treatment and Pharmacology (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Hematology (611 citations), Oncology (534 citations), Genetics (205 citations), Molecular Biology (1.2k citations) and Cancer Research (139 citations). Mack Mabry has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Barry D. Nelkin, Stephen B. Baylin, Michael Borges, Douglas W. Ball, R. Ilona Linnoila, Helgi J. K. van de Velde, Herbert Chen, Martin Dunbar, Jalaja Potluri and Brenda Chyla. Their work appears in journals such as Blood, Journal of Clinical Oncology, Investigational New Drugs, Lung Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.